Johnson & Johnson: Global Pharmaceutical Cold Chain Cases

Challenge

Johnson & Johnson is a global pharmaceutical and medical devices leader with $90B+ revenue and 60+ countries. They need cases for vaccine samples, oncology drug materials, and medical device kits transported to hospitals and treatment centers globally. Cases must: (1) meet IATA + GDP + WHO PQS cold chain standards, (2) maintain 2-8C for 72+ hours, (3) protect $200,000+ pharma cargo, (4) integrate with J&J supply chain, (5) be reusable 200+ cycles.

Solution

KeXinMaterials provided pharma-grade cold chain cases with: (1) IATA + GDP + WHO PQS + IP65 compliance, (2) PP copolymer with insulated walls and phase-change material chambers, (3) custom foam + PCM for J&J Janssen vaccines, oncology drugs, medical device kits, (4) serialized QR + J&J cold chain logistics, (5) 200+ cycle rating. Custom foam for J&J COVID-19 vaccine, Stelara, Darzalex, Tremfya, Imbruvica, medical device kits.

Result

1,800 cases deployed across 60+ countries. 18 months zero temperature excursion. 100% WHO PQS compliance. Johnson & Johnson standardized KeXinMaterials as a qualified pharma cold chain case vendor.

"Johnson & Johnson operates in 60+ countries with strict IATA, GDP, and WHO PQS pharmaceutical cold chain standards. KeXinMaterials cases have proven 2-8C maintenance for 72+ hours across our global pharmaceutical distribution including J&J Janssen vaccines. The 200+ cycle reusability supports our ESG goals. They're our standard pharma case. — J&J Global Pharma Logistics Director"

— Johnson & Johnson

Related Resources

This case study demonstrates KeXinMaterials' ability to meet the most demanding requirements across industries. The same engineering rigor applies across all our 220+ case studies. For similar projects, contact us at kexin@beeaa.com for a 12h custom quote.